This joint resolution repeals specified authorizations for the use of military force against Iraq.
This resolution designates September 15, 2021, as International Myotonic Dystrophy Awareness Day. Myotonic dystrophy is an inherited disorder characterized by progressive muscle loss and weakness.
This resolution condemns the Chinese Communist Party and its violation of the human rights of the people of China.
Drug Shortages Prevention and Quality Improvement Act This bill addresses shortages of essential drugs and related issues. (Generally, an essential drug is one that is life-supporting, life-sustaining, or intended to treat or prevent a debilitating condition.) The Food and Drug Administration (FDA) may require a manufacturer of an essential drug to (1) submit data, or conduct studies to gather data, to determine the longest supported expiration date of a drug; or (2) make labeling changes regarding a drug's expiration period based on data provided under this bill or otherwise available to the FDA. The bill establishes civil monetary penalties for a manufacturer that (1) refuses such a request to provide data or modify a drug label's expiration information, or (2) fails to meet certain requirements to provide to the FDA timely information about essential drug shortages. The Government Accountability Office must conduct a study examining the process by which prescription drug manufacturers provide shelf life data to the FDA. The FDA must establish a pilot program to assess the facilities and processes of participating manufacturers of prescription sterile injectable drugs that have been deemed essential under a specified executive order. The assessment shall cover topics including supply chain management, manufacturing strategy and operations, and workforce management. Furthermore, the FDA must provide grants to certain nonprofit entities and institutions of higher education that agree to participate in the above pilot program. The grant funds must be used to upgrade the recipient's drug manufacturing facilities to utilize advanced manufacturing capabilities.
Right to Vote Act This bill addresses the right to vote in federal elections. Specifically, the bill declares that every citizen of legal voting age shall have the fundamental right to vote in federal elections. In addition, the bill prohibits federal, state, and local governments from substantially impairing the ability to vote in federal elections unless the government action furthers an important and particularized governmental interest. Further, the bill specifies that a government may not diminish the ability to vote in federal elections unless the action uses the least restrictive means to achieve such an interest. A violation of rights created by the bill may be challenged in district court, and a prevailing plaintiff may receive attorney fees. The bill outlines judicial review standards for challenges to voting practices.
Healthy Dog Importation Act This bill imposes requirements on the importation of live dogs. Specifically, the bill prohibits the importation of a live dog into the United States unless the Department of Agriculture (USDA) determines the dog (1) is in good health, (2) has received all necessary vaccinations and demonstrated negative test results as evidenced by a certificate from a licensed veterinarian, and (3) is officially identified by a permanent method approved by USDA. Additionally, dogs entering the United States for transfer must be at least six months of age and accompanied by a USDA permit. Transfer is defined as a change of ownership or control of an imported dog to another person, including by sale, adoption, exchange, or donation. USDA must provide an exception to any requirements under the bill for dogs that are transferred for (1) research purposes; (2) veterinary treatment under certain conditions, including appropriate quarantining; or (3) lawful importation into the state of Hawaii if the dog is not transported out of Hawaii for transfer at less than six months of age. USDA also has enforcement authority under the bill.
Global Migration Agreement Act This bill requires the Department of State to promote in bilateral relationships and multilateral organizations the adoption of a binding Global Migration Agreement. Among other purposes, such agreement should (1) address the root causes of migration; (2) centralize the human rights of migrants, recognizing the particular vulnerabilities of marginalized groups; and (3) provide global funding for crisis response involving both internal and cross-border migrants at risk.
Stop Arming Human Rights Abusers Act This bill imposes certain sanctions on countries that violate international human rights law or international humanitarian law. Specifically, the bill prohibits the provision of security assistance to, the sale or commercial export of arms to, or the exchange of law enforcement with a foreign country that has committed genocide, crimes against humanity, or war crimes. The bill also establishes the U.S. Commission on Atrocity Accountability and Human Rights to review such violations of international human rights law or international humanitarian law and to make policy recommendations with respect to the imposition of sanctions for such violations.
This concurrent resolution recognizes the disparity in wages paid to Black women and its impact on women, families, and the nation, and reaffirms Congress' support for ensuring equal pay and closing the gender wage gap.
This concurrent resolution recognizes the disparity in wages paid to Black women and its impact on women, families, and the nation, and reaffirms Congress' support for ensuring equal pay and closing the gender wage gap.
This resolution expresses support for the designation of the first Monday in March as COVID-19 Victims and Survivors Memorial Day.
Comprehensive TB Elimination Act of 2021 This bill reauthorizes for FY2022-FY2027 and revises the tuberculosis (TB) prevention and treatment grant program administered by the Centers for Disease Control and Prevention. The Health Resources and Services Administration may also award grants for TB prevention and treatment efforts to (1) state and local governments; (2) Indian tribes, Native Hawaiian health organizations, and related entities; and (3) community health centers and federally qualified health centers. Additionally, the Government Accountability Office must report on national TB prevention and treatment efforts.
